Aspen Wealth Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381K Sell
1,558
-85
-5% -$19.8K 0.2% 64
2025
Q4
$340K Hold
1,643
0.19% 64
2025
Q3
$305K Buy
1,643
+191
+13% +$32.7K 0.17% 72
2025
Q2
$222K Sell
1,452
-150
-9% -$23.1K 0.13% 80
2025
Q1
$266K Sell
1,602
-80
-5% -$12.5K 0.17% 70
2024
Q4
$243K Sell
1,682
-108
-6% -$16.7K 0.16% 73
2024
Q3
$290K Buy
1,790
+32
+2% +$5.1K 0.19% 70
2024
Q2
$275K Buy
1,758
+157
+10% +$23.4K 0.19% 62
2024
Q1
$253K Hold
1,601
0.17% 68
2023
Q4
$251K Sell
1,601
-48
-3% -$7.36K 0.18% 70
2023
Q3
$257K Hold
1,649
0.2% 61
2023
Q2
$273K Sell
1,649
-1,276
-44% -$206K 0.21% 62
2023
Q1
$453K Buy
2,925
+189
+7% +$30.5K 0.35% 43
2022
Q4
$483K Buy
+2,736
New +$472K 0.39% 38

Other funds holding JNJ

Aspen Wealth Strategies's JNJ Position: Q1 2026 in Review

Aspen Wealth Strategies reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q1 2026, selling an estimated $19.8K and leaving 1,558 shares worth $381K. The position accounts for 0.2% of the portfolio, ranked #64.

Aspen Wealth Strategies first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $483K in Q4 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aspen Wealth Strategies held 1,558 shares of Johnson & Johnson worth $381K as of Q1 2026.
  • Aspen Wealth Strategies sold 85 Johnson & Johnson shares in Q1 2026, an estimated $19.8K.
  • Johnson & Johnson made up 0.2% of Aspen Wealth Strategies's portfolio in Q1 2026, its #64 holding.
  • Aspen Wealth Strategies first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Aspen Wealth Strategies's Johnson & Johnson position peaked at $483K in Q4 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aspen Wealth Strategies's 13F filing for Q1 2026, filed 8 May 2026.